Skip to main content
. 2022 Jul 12;13:921337. doi: 10.3389/fphar.2022.921337

FIGURE 4.

FIGURE 4

Binding studies of selected ingredients–targets interactions. (A) AKT with Stigmasterol; (B) AKT1 with Corymbosin; (C) GAPDH with quercetin; (D) AKT1 with beta-sitosterol; (E) AKT1 with quercetin.